Why the study?
Does the Ca(2+) channel stabilizer S107 prevent SR Ca(2+) leak and arrhythmias in the mdx mouse model of Duchenne muscular dystrophy?
Does the Ca(2+) channel stabilizer S107 prevent SR Ca(2+) leak and arrhythmias in the mdx mouse model of Duchenne muscular dystrophy?
In a mouse model of Duchenne muscular dystrophy, stabilizing the RyR2 channel with S107 prevents diastolic SR calcium leak and subsequent fatal cardiac arrhythmias.
Should not yet change DMD practice; extends RyR2 stabilization evidence in mdx mice.
Patients with Duchenne muscular dystrophy (DMD) have a progressive dilated cardiomyopathy associated with fatal cardiac arrhythmias. Electrical and functional abnormalities have been attributed to cardiac fibrosis; however, electrical abnormalities may occur in the absence of overt cardiac histopathology. Here we show that structural and functional remodeling of the cardiac sarcoplasmic reticulum (SR) Ca(2+) release channel/ryanodine receptor (RyR2) occurs in the mdx mouse model of DMD. RyR2 from mdx hearts were S-nitrosylated and depleted of calstabin2 (FKBP12.6), resulting in "leaky" RyR2 channels and a diastolic SR Ca(2+) leak. Inhibiting the depletion of calstabin2 from the RyR2 complex with the Ca(2+) channel stabilizer S107 ("rycal") inhibited the SR Ca(2+) leak, inhibited aberrant depolarization in isolated cardiomyocytes, and prevented arrhythmias in vivo. This suggests that diastolic SR Ca(2+) leak via RyR2 due to S-nitrosylation of the channel and calstabin2 depletion from the channel complex likely triggers cardiac arrhythmias. Normalization of the RyR2-mediated diastolic SR Ca(2+) leak prevents fatal sudden cardiac arrhythmias in DMD.
No takes yet. Share an insight, caveat, or question.
Fauconnier et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: